Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To assess the effectiveness of the Buteyko method as an adjunct therapy in the treatment of asthmatic children with mouth breathing.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Buteyko Method | Experimental | Children will perform 6 sessions (twice a week) of treatment with the Buteyko Method. |
|
| Control | No Intervention | Asthma education. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Buteyko Method | Other | Intervention will be held twice a week during 3 weeks. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in Sleep disturbance (questionnaire) | Sleep disturbance will be assessed by the sleep disturbance scale for children (SDSC). | Baseline, three weeks later and six months after treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Change in spirometry (FVC, FEV1, FEV1/FVC, FEF25-75%, PEF) | Baseline, three weeks later and six months after treatment | |
| Change in ventilometry (minute volume and vital capacity) | Minute volume and vital capacity (liters) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Universidade Federal do Rio Grande do Norte (UFRN) | Natal | Rio Grande do Norte | 59078970 | Brazil |
Not provided
| ID | Term |
|---|---|
| D001249 | Asthma |
| D009058 | Mouth Breathing |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Baseline, three weeks later and six months after treatment |
| Number of hospitalizations | Through study completion, an average of three weeks and six months after treatment |
| Number of days off-school | During the three weeks of treatment |
| D012130 |
| Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
| D012120 | Respiration Disorders |
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |